Trademark: 79212480
Status Date
Tuesday, December 25, 2018
Registration Number
5634868
Registration Date
Tuesday, December 25, 2018
Filing Date
Tuesday, March 7, 2017
Published for Opposition
Tuesday, October 9, 2018
40 Custom manufacture of cosmetic preparations, pharmaceutical preparations and/or chemical preparations for use in industry, intermediate and finished formulations, and single constituents; Custom manufacture of biological tissue and of biotechnological products for use in research; Custom manufacture of cosmetics to order and according to customer requirements; Custom manufacture for others of biological production platforms, biotechnology production platforms for protein production, mammalian and human cells for protein production, organoid production for testing purposes, to order and according to customer requirements
9 Software for medical applications for diagnosing and monitoring tissue healing in dermatology, orthopedics, and gynecology
5 Pharmaceutical, biological or biotechnological products for curing or treating dermatological, gynecological and orthopedic conditions namely, pharmaceutical preparations for treating dermatological, gynecological and orthopedic conditions; wound dressing containing foetal cell based/derived proteins; protein augmented surfaces for orthopaedic implants, namely, implantable scaffolds comprising living tissue primarily comprised of proteins; wound dressing containing foetal cell based/derived proteins for which the cells were cultured in conditions as to produce these proteins; protein augmented surfaces for orthopaedic implants, namely, implantable scaffolds comprising living tissue primarily comprised of proteins for orthopaedic implants; pharmaceutical, biological or biotechnological preparations, namely, specialty medicated cosmetic creams, wound dressings, implantable scaffolds comprising living tissue for enhancing therapy or maintaining tissue contour, and cell derivatives being stem cells for medical use for tissue regeneration; pharmaceutical, biological or biotechnological preparations for medical use for treatment ofgynecological illnesses; biological or biotechnological preparations for medical use for treatment of orthopedic injuries; Pharmaceutical, biological or biotechnological preparations for medical use for activating cellular functions namely, for treatment of foetal cell derived structural and adhesion proteins to alter immune responses or enhance wound healing, growth supplements for manufacturing of cell therapies
3 Cosmetic preparations, namely, preparations for cleaning, protecting and maintaining in good condition various parts of the human and animal body surface; cosmetic preparations for regeneration of the skin and mucous membranes; cosmetic preparations for personal use
44 Medical services and providing of medical information in the medical field; Medical testing and analysis for diagnostic purposes; Medical consultation services provided by consultants relating to pharmaceutical, biological, biotechnological, cosmetic and medical products
10 Matrices for wound dressings in the nature of interactive wound dressings primarily composed of non-living tissue for medical use comprising artificial or organically derived but non-living scaffold materials alone or in combination with cells or cell derivatives to protect the skin and heal skin related conditions, burns, ulcers, cuts, and surgical incisions; Matrices for wound dressings in the nature of interactive wound dressings primarily composed of non-living tissue for medical use comprising artificial or organic gels or creams alone or in combination with non-living cell derivatives to protect the skin and heal skin related conditions burns, ulcers, cuts, and surgical incisions; Matrices for tissue regeneration in the nature of implantable dermatology scaffolds comprising artificial or non-living organic materials alone or in combination with cells or cell derivatives for maintaining tissue contour during tissue regeneration; Matrices in the nature of interactive wound dressings primarily composed of non-living tissue for medical use comprising artificial or non-living organic scaffold materials alone or in combination with cells or cell derivatives to protect gynecologic and urologic intimate zones and heal related conditions, lacerations, dryness, and blistering; Matrices in the nature of interactive wound dressings primarily composed of non-living tissue for medical use comprising artificial or organic gels or creams alone or in combination with cells or cell derivatives to protect gynecologic and urologic intimate zones and heal related conditions, lacerations, dryness, and blistering; Matrices for tissue regeneration in the nature of implantable gynecology scaffolds comprising artificial or non-living organic materials alone or in combination with cells or cell derivatives for maintaining tissue contour during tissue regeneration; Matrices for tissue regeneration comprising artificial or non-living organic scaffold materials alone or in combination with cells or cell derivatives to heal bone, cartilage, tendon related conditions, tendinopathies, and fractures; Matrices for tissue regeneration comprising artificial or organic gels or creams alone or in combination with cells or cell derivatives to heal bone, cartilage, tendon related conditions, tendinopathies, and fractures; Matrices for tissue regeneration in the nature of implantable orthopedic scaffolds comprising artificial or non- living organic materials alone or in combination with cells or cell derivatives for maintaining tissue contour during tissue regeneration
42 Scientific research consulting services provided by consultants in the fields of pharmaceutical, biological, biotechnological, medical and cosmetic research, preclinical and safety assessments
Dec 25, 2023
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Jul 11, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 11, 2022
Teas Change Of Correspondence Received
Jul 11, 2022
Teas Change Of Domestic Representatives Address
Jul 11, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Jul 11, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 11, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 11, 2022
Teas Change Of Owner Address Received
Apr 26, 2019
Final Decision Transaction Processed By Ib
Apr 5, 2019
Final Disposition Notice Sent To Ib
Apr 5, 2019
Final Disposition Processed
Mar 25, 2019
Final Disposition Notice Created, To Be Sent To Ib
Jan 5, 2019
Notification Of Possible Opposition - Processed By Ib
Dec 25, 2018
Registered-Principal Register
Dec 19, 2018
Notification Of Possible Opposition Sent To Ib
Dec 19, 2018
Notification Of Possible Opposition Created, To Be Sent To Ib
Oct 9, 2018
Official Gazette Publication Confirmation E-Mailed
Oct 9, 2018
Published For Opposition
Oct 6, 2018
Notification Processed By Ib
Sep 19, 2018
Notification Of Possible Opposition Sent To Ib
Sep 19, 2018
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Sep 19, 2018
Notification Of Notice Of Publication E-Mailed
Sep 4, 2018
Approved For Pub - Principal Register
Aug 31, 2018
Examiner's Amendment Entered
Aug 31, 2018
Assigned To Lie
Aug 31, 2018
Notification Of Examiners Amendment E-Mailed
Aug 31, 2018
Examiners Amendment E-Mailed
Aug 31, 2018
Examiners Amendment -Written
Jun 7, 2018
New Representative At Ib Received
Mar 1, 2018
Notification Of Final Refusal Emailed
Mar 1, 2018
Final Refusal E-Mailed
Mar 1, 2018
Final Refusal Written
Feb 14, 2018
Teas/Email Correspondence Entered
Feb 13, 2018
Correspondence Received In Law Office
Feb 13, 2018
Teas Response To Office Action Received
Sep 1, 2017
Refusal Processed By Ib
Aug 17, 2017
Non-Final Action Mailed - Refusal Sent To Ib
Aug 17, 2017
Refusal Processed By Mpu
Aug 1, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Jul 31, 2017
Non-Final Action Written
Jul 29, 2017
Non-Final Action (Ib Refusal) Withdrawn For Review
Jul 24, 2017
Non-Final Action (Ib Refusal) Prepared For Review
Jul 23, 2017
Non-Final Action Written
Jul 18, 2017
Application Filing Receipt Mailed
Jul 14, 2017
Assigned To Examiner
Jul 14, 2017
New Application Office Supplied Data Entered
Jul 13, 2017
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
